Literature DB >> 27450223

Assessment of the diagnostic performance of the IDS-iSYS tests for toxo IgG, toxo IgM and avidity.

Pauline Levigne1, François Peyron2, Martine Wallon1.   

Abstract

When acquired during pregnancy toxoplasmosis can have devastating consequences on the fetus. As maternal infection is in the majority of cases subclinical, the diagnosis of toxoplasmosis relies on serological tests for the detection of IgG, IGM and the mesure of IgG avidity. We evaluated the performance of IDS-iSYS a new automatized instrument based on chemiluminescence for the diagnosis of the disease. Our study was based on non-selected samples received in our laboratory either for the determination of serological status or for distinguishing acute from chronic infection. Seven hundred eighty three samples were enrolled in the study. Compared with Architect IgG and IgM assays, the sensitivity and specificity were respectively 99% and 99% for IgG, and 75% and 97% for IgM. We observed higher remaining titers for IDS iSYS IgG, which could reduce the proportions of patients who have to be retested because of doubtful titers. IgM detection and avidity scored equivalent performance with both methods. This automate appears to be a reliable and easy-to-use tool for diagnosing toxoplasmosis in different clinical settings.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Architect; IDS-iSYS; Serologic diagnosis; Toxoplasmosis

Mesh:

Substances:

Year:  2016        PMID: 27450223     DOI: 10.1016/j.diagmicrobio.2016.07.006

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  2 in total

1.  Performance of seven commercial automated assays for the detection of low levels of anti-Toxoplasma IgG in French immunocompromised patients.

Authors:  Tiphaine Douet; Catherine Armengol; Elena Charpentier; Pamela Chauvin; Sophie Cassaing; Xavier Iriart; Antoine Berry; Judith Fillaux
Journal:  Parasite       Date:  2019-08-23       Impact factor: 3.000

2.  Anti-Toxoplasma IgG assays: What performances for what purpose? A systematic review.

Authors:  Florence Robert-Gangneux; Hélène Guegan
Journal:  Parasite       Date:  2021-04-26       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.